Effectiveness of the monovalent rotavirus vaccine in Colombia: A case-control study

Vaccine

Volumn 32, Issue 25, 2014, Pages 3035-3040

  Cotes Cantillo, Karol ^a   Paternina Caicedo, Angel ^b   Coronell Rodríguez, Wilfrido ^b   Alvis Guzmán, Nelson ^b   Parashar, Umesh D ^c   Patel, Manish ^c   De la Hoz Restrepo, Fernando ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DE CARTAGENA   (Colombia)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Diarrhea; Rotavirus; Vaccine; Vaccine effectiveness

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE DIARRHEA; ARTICLE; BREAST FEEDING; CHILD; CLINICAL EFFECTIVENESS; COLOMBIA; CONTROLLED STUDY; DAY CARE; DIAGNOSTIC TEST; DIARRHEA; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG EFFICACY; EDUCATIONAL STATUS; EMERGENCY WARD; FECES ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; INCOME; INFANT; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ROTAVIRUS INFECTION; VACCINATION;

DIARRHEA; ROTAVIRUS; VACCINE; VACCINE EFFECTIVENESS;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; COLOMBIA; DIARRHEA, INFANTILE; FECES; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 84899897090     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.03.064     Document Type: Article

References (24)

1. Walker C.L., et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013.
2. Lozano R., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2095-2128.
3. Tate J.E., et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(2):136-141.
4. Vesikari T., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(1):23-33.
5. Ruiz-Palacios G.M., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(1):11-22.
6. Nelson E.A., Glass R.I. Rotavirus: realising the potential of a promising vaccine. Lancet 2010, 376(9741):568-570.
7. Boom J.A., et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010, 125(2):e199-e207.
8. Correia J.B., et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010, 201(3):363-369.
9. Justino M.C., et al. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belem: Brazil. Pediatr Infect Dis J 2011, 30(5):396-401.
10. Muhsen K., et al. Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study. Hum Vaccin 2010, 6(6):450-454.
11. Patel M., et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 2012, 130(2):e365-e372.
12. Snelling T.L., et al. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia. Clin Infect Dis: Off Publ Infect Dis Soc Am 2011, 52(2):191-199.
13. Staat M.A., et al. Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011, 128(2):e267-e275.
14. de Palma O., et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010, 340:c2825.
15. Patel M., et al. Oral rotavirus vaccines: how well will they work where they are needed most?. J Infect Dis 2009, 200(Suppl 1):S39-48.
16. World Health Organization Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. Immunization, vaccines and biologicals 2008, WHO, Geneva. World Health Organization (Ed.).
17. Cunliffe N.A., et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine 2012, 30(Suppl 1):A36-A43.
18. De la Hoz F., et al. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia. Vaccine 2010, 28(22):3856-3864.
19. Hull J.J., et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011, 30(1 Suppl):S42-S47.
20. Ruuska T., Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990, 22(3):259-267.
21. Smith P.G., Rodrigues L.C., Fine P.E. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984, 13(1):87-93.
22. Caceres D.C., et al. Burden of rotavirus-related disease among children under five: Colombia, 2004. Rev Panam Salud Publica 2006, 20(1):9-21.
23. Patel M.M., et al. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?. Lancet Infect Dis 2012, 12(7):561-570.
24. Patel M.M., et al. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ 2013, 346:f3726.